{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:22Z","timestamp":1786979962374,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009091","name":"justus liebig universit\u00e4t gie\u00dfen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009091","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Justus-Liebig-Universit\u00e4t Gie\u00dfen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The objective is to evaluate the attitude of rheumatologists regarding the use of COVID-19 vaccination in patients with inflammatory rheumatic diseases (IRDs). From February 2nd until March 15th, 2021, rheumatologists from Germany were asked to participate anonymously in a survey addressing their attitude with respect to COVID-19 vaccinations of IRD patients. The survey was completed by 214 participants (107 men, 103 women, 4 unspecified). More than half of the physicians (61%) were working in rheumatologic private practices and 62% had more than 20\u00a0years of experience in rheumatology. 90% reported to be at least confidential in handling issues of COVID-19 vaccination and 99% would recommend COVID-19 vaccination for IRD patients. The majority would not recommend to stop or reduce immunomodulatory drugs for vaccination except for rituximab. More than 70% would prefer vaccination with a mRNA vaccine for their IRD patients. This study shows that almost all rheumatologists in Germany support the COVID-19 vaccination for their IRD patients without reducing or terminating the actual immunomodulatory medication to potentially improve the response to the vaccine. This attitude is in accordance with the current recommendations of the German Society of Rheumatology regarding COVID-19 vaccination in IRD patients, and indicates that these have been well accepted and work in everyday clinical practice.<\/jats:p>","DOI":"10.1007\/s00296-021-04986-1","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T13:02:48Z","timestamp":1631106168000},"page":"1949-1956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in Germany"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2982-8253","authenticated-orcid":false,"given":"Rebecca","family":"Hasseli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2709-6685","authenticated-orcid":false,"given":"Alexander","family":"Pfeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1681-491X","authenticated-orcid":false,"given":"Hendrik","family":"Schulze-Koops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2504-3229","authenticated-orcid":false,"given":"Christof","family":"Specker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the COVID-19 Task Force of the German Society for Rheumatology (DGRh)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimba","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns-Martin","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Regierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Schmeiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Strangfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Voll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Voormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"4986_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/ajcp\/aqaa272","volume":"155","author":"K Kadkhoda","year":"2021","unstructured":"Kadkhoda K (2021) Herd immunity to COVID-19. Am J Clin Pathol 155:471\u2013472. https:\/\/doi.org\/10.1093\/ajcp\/aqaa272","journal-title":"Am J Clin Pathol"},{"key":"4986_CR2","unstructured":"Cohen J (2020) Science\u2019s breakthrough of the year 2020: shots of hope. 2020. https:\/\/vis.sciencemag.org\/breakthrough2020\/. Accessed 21 Aug 2021"},{"key":"4986_CR3","unstructured":"Robert-Koch-Institute (2021) RKI-Infektionskrankheiten A-Z-STIKO-Empfehlungen zur COVID-19-Impfung. https:\/\/www.rki.de\/DE\/Content\/Infekt\/Impfen\/ImpfungenAZ\/COVID-19\/Impfempfehlung-Zusfassung.html?nn=2386228. Accessed 21 Aug 2021"},{"key":"4986_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00393-020-00955-4","volume":"80","author":"C Specker","year":"2021","unstructured":"Specker C, Schulze-Koops H (2021) Impfung gegen SARS-CoV-2 bei entz\u00fcndlich rheumatischen Erkrankungen: Empfehlungen der DGRh f\u00fcr \u00c4rzte und Patienten. [Vaccination against SARS-CoV-2 in inflammatory rheumatic diseases\u202f: Recommendations of the German Society for Rheumatology for physicians and patients]. Z Rheumatol 80:43\u201344. https:\/\/doi.org\/10.1007\/s00393-020-00955-4","journal-title":"Z Rheumatol"},{"key":"4986_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001553","volume":"7","author":"H Schulze-Koops","year":"2021","unstructured":"Schulze-Koops H, Specker C, Skapenko A (2021) Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. RMD Open 7:e001553. https:\/\/doi.org\/10.1136\/rmdopen-2020-001553","journal-title":"RMD Open"},{"key":"4986_CR6","unstructured":"European League Against Rheumatism (EULAR) (2020) EULAR guidance for patients COVID-19 outbreak. https:\/\/www.eular.org\/eular_guidance_for_patients_covid19_outbreak.cfm. Accessed 21 Aug 2021"},{"key":"4986_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00077-1","author":"M Dougados","year":"2021","unstructured":"Dougados M (2021) Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic. Lancet Rheumatol. https:\/\/doi.org\/10.1016\/S2665-9913(21)00077-1","journal-title":"Lancet Rheumatol"},{"key":"4986_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab223","author":"J Arnold","year":"2021","unstructured":"Arnold J, Winthrop K, Emery P (2021) COVID-19 vaccination and antirheumatic therapy. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keab223","journal-title":"Rheumatology (Oxford)"},{"key":"4986_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","volume":"79","author":"V Furer","year":"2020","unstructured":"Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M et al (2020) 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 79:39\u201352. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215882","journal-title":"Ann Rheum Dis"},{"key":"4986_CR10","unstructured":"Leiner DJ (2019) SoSci Survey (Version 3.1.06) [Computer software]. https:\/\/www.soscisurvey.de"},{"key":"4986_CR11","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e398","volume":"35","author":"PS Gaur","year":"2020","unstructured":"Gaur PS, Zimba O, Agarwal V, Gupta L (2020) Reporting survey based studies\u2014a primer for authors. J Korean Med Sci 35:e398. https:\/\/doi.org\/10.3346\/jkms.2020.35.e398","journal-title":"J Korean Med Sci"},{"key":"4986_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220272","author":"UM Geisen","year":"2021","unstructured":"Geisen UM, Berner DK, Tran F, S\u00fcmb\u00fcl M, Vullriede L, Ciripoi M et al (2021) Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220272","journal-title":"Ann Rheum Dis"},{"key":"4986_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001041","volume":"5","author":"V Furer","year":"2019","unstructured":"Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N et al (2019) Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open 5:e001041. https:\/\/doi.org\/10.1136\/rmdopen-2019-001041","journal-title":"RMD Open"},{"key":"4986_CR14","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00296-021-04941-0","volume":"41","author":"N Hammam","year":"2021","unstructured":"Hammam N, Tharwat S, Shereef RRE, Elsaman AM, Khalil NM, Fathi HM et al (2021) Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt. Rheumatol Int 41:1607\u20131616. https:\/\/doi.org\/10.1007\/s00296-021-04941-0","journal-title":"Rheumatol Int"},{"key":"4986_CR15","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00296-021-04841-3","volume":"41","author":"B Yurttas","year":"2021","unstructured":"Yurttas B, Poyraz BC, Sut N, Ozdede A, Oztas M, U\u011furlu S et al (2021) Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey. Rheumatol Int 41:1105\u20131114. https:\/\/doi.org\/10.1007\/s00296-021-04841-3","journal-title":"Rheumatol Int"},{"key":"4986_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13075-015-0663-9","volume":"17","author":"L Fischer","year":"2015","unstructured":"Fischer L, Gerstel PF, Poncet A, Siegrist C-A, Laffitte E, Gabay C et al (2015) Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases\u2014a longitudinal study. Arthritis Res Ther 17:151. https:\/\/doi.org\/10.1186\/s13075-015-0663-9","journal-title":"Arthritis Res Ther"},{"key":"4986_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/ard.2005.036434","volume":"65","author":"I Fomin","year":"2006","unstructured":"Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D et al (2006) Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65:191\u2013194. https:\/\/doi.org\/10.1136\/ard.2005.036434","journal-title":"Ann Rheum Dis"},{"key":"4986_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/rheumatology\/ker389","volume":"51","author":"S Adler","year":"2012","unstructured":"Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J et al (2012) Protective effect of A\/H1N1 vaccination in immune-mediated disease\u2013a prospectively controlled vaccination study. Rheumatology (Oxford) 51:695\u2013700. https:\/\/doi.org\/10.1093\/rheumatology\/ker389","journal-title":"Rheumatology (Oxford)"},{"key":"4986_CR19","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1093\/rheumatology\/kes202","volume":"51","author":"ILA Fran\u00e7a","year":"2012","unstructured":"Fran\u00e7a ILA, Ribeiro ACM, Aikawa NE, Saad CGS, Moraes JCB, Goldstein-Schainberg C et al (2012) TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients. Rheumatology (Oxford) 51:2091\u20132098. https:\/\/doi.org\/10.1093\/rheumatology\/kes202","journal-title":"Rheumatology (Oxford)"},{"key":"4986_CR20","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/art.30325","volume":"63","author":"C Gabay","year":"2011","unstructured":"Gabay C, Bel M, Combescure C, Ribi C, Meier S, Posfay-Barbe K et al (2011) Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheumatol 63:1486\u20131496. https:\/\/doi.org\/10.1002\/art.30325","journal-title":"Arthritis Rheumatol"},{"key":"4986_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1159\/000119742","volume":"28","author":"M Keshtkar-Jahromi","year":"2008","unstructured":"Keshtkar-Jahromi M, Argani H, Rahnavardi M, Mirchi E, Atabak S, Tara SA et al (2008) Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephrol 28:654\u2013660. https:\/\/doi.org\/10.1159\/000119742","journal-title":"Am J Nephrol"},{"key":"4986_CR22","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/acr.22246","volume":"66","author":"C Hua","year":"2014","unstructured":"Hua C, Barnetche T, Combe B, Morel J (2014) Effect of methotrexate, anti-tumor necrosis factor \u03b1, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 66:1016\u20131026. https:\/\/doi.org\/10.1002\/acr.22246","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4986_CR23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1136\/annrheumdis-2018-213222","volume":"77","author":"JK Park","year":"2018","unstructured":"Park JK, Lee YJ, Shin K, Ha Y-J, Lee EY, Song YW et al (2018) Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis 77:898\u2013904. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213222","journal-title":"Ann Rheum Dis"},{"key":"4986_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","volume":"45","author":"MC Kapetanovic","year":"2006","unstructured":"Kapetanovic MC, Saxne T, Sj\u00f6holm A, Truedsson L, J\u00f6nsson G, Geborek P (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45:106\u2013111. https:\/\/doi.org\/10.1093\/rheumatology\/kei193","journal-title":"Rheumatology (Oxford)"},{"key":"4986_CR25","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1136\/annrheumdis-2019-215187","volume":"78","author":"JK Park","year":"2019","unstructured":"Park JK, Choi Y, Winthrop KL, Song YW, Lee EB (2019) Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial. Ann Rheum Dis 78:1283\u20131284. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215187","journal-title":"Ann Rheum Dis"},{"key":"4986_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.semarthrit.2008.12.002","volume":"39","author":"O Elkayam","year":"2010","unstructured":"Elkayam O, Bashkin A, Mandelboim M, Litinsky I, Comaheshter D, Levartovsky D et al (2010) The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 39:442\u2013447. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.12.002","journal-title":"Semin Arthritis Rheum"},{"key":"4986_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2020.08.002","author":"D Ben Nessib","year":"2020","unstructured":"Ben Nessib D, Fazaa A, Miladi S, Sellami M, Ouenniche K, Souabni L et al (2020) Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature. Therapie. https:\/\/doi.org\/10.1016\/j.therap.2020.08.002","journal-title":"Therapie"},{"key":"4986_CR28","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3899\/jrheum.130945","volume":"41","author":"AJ Kivitz","year":"2014","unstructured":"Kivitz AJ, Schechtman J, Texter M, Fichtner A, de Longueville M, Chartash EK (2014) Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial. J Rheumatol 41:648\u2013657. https:\/\/doi.org\/10.3899\/jrheum.130945","journal-title":"J Rheumatol"},{"key":"4986_CR29","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1128\/CVI.00386-12","volume":"19","author":"A Chioato","year":"2012","unstructured":"Chioato A, Noseda E, Stevens M, Gaitatzis N, Kleinschmidt A, Picaud H (2012) Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study. Clin Vaccine Immunol 19:1597\u20131602. https:\/\/doi.org\/10.1128\/CVI.00386-12","journal-title":"Clin Vaccine Immunol"},{"key":"4986_CR30","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1136\/annrheumdis-2012-201950","volume":"71","author":"S Mori","year":"2012","unstructured":"Mori S, Ueki Y, Hirakata N, Oribe M, Hidaka T, Oishi K (2012) Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis. Ann Rheum Dis 71:2006\u20132010. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201950","journal-title":"Ann Rheum Dis"},{"key":"4986_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3109\/14397595.2013.843743","volume":"24","author":"T Tsuru","year":"2014","unstructured":"Tsuru T, Terao K, Murakami M, Matsutani T, Suzaki M, Amamoto T et al (2014) Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab. Mod Rheumatol 24:511\u2013516. https:\/\/doi.org\/10.3109\/14397595.2013.843743","journal-title":"Mod Rheumatol"},{"key":"4986_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12891-016-1082-z","volume":"17","author":"R Alten","year":"2016","unstructured":"Alten R, Bingham CO, Cohen SB, Curtis JR, Kelly S, Wong D, Genovese MC (2016) Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept. BMC Musculoskelet Disord 17:231. https:\/\/doi.org\/10.1186\/s12891-016-1082-z","journal-title":"BMC Musculoskelet Disord"},{"key":"4986_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/acr.21838","volume":"65","author":"AC Ribeiro","year":"2013","unstructured":"Ribeiro AC, Laurindo IM, Guedes LK, Saad CG, Moraes JC, Silva CA, Bonfa E (2013) Abatacept and reduced immune response to pandemic 2009 influenza A\/H1N1 vaccination in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 65:476\u2013480. https:\/\/doi.org\/10.1002\/acr.21838","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4986_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/art.41734","author":"JR Curtis","year":"2021","unstructured":"Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR et al (2021) American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal Diseases\u2014Version 1. Arthritis Rheumatol (Hoboken, NJ). https:\/\/doi.org\/10.1002\/art.41734","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"4986_CR35","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/ard.2007.077461","volume":"67","author":"S Oren","year":"2008","unstructured":"Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I et al (2008) Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Ann Rheum Dis 67:937\u2013941. https:\/\/doi.org\/10.1136\/ard.2007.077461","journal-title":"Ann Rheum Dis"},{"key":"4986_CR36","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.vaccine.2010.12.072","volume":"29","author":"U Arad","year":"2011","unstructured":"Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I et al (2011) The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab. Vaccine 29:1643\u20131648. https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.072","journal-title":"Vaccine"},{"key":"4986_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/art.25033","volume":"62","author":"S van Assen","year":"2010","unstructured":"van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE et al (2010) Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheumatol 62:75\u201381. https:\/\/doi.org\/10.1002\/art.25033","journal-title":"Arthritis Rheumatol"},{"key":"4986_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/annrheumdis-2014-207191","volume":"75","author":"KL Winthrop","year":"2016","unstructured":"Winthrop KL, Silverfield J, Racewicz A, Neal J, Lee EB, Hrycaj P et al (2016) The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis. Ann Rheum Dis 75:687\u2013695. https:\/\/doi.org\/10.1136\/annrheumdis-2014-207191","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04986-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04986-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04986-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T06:18:39Z","timestamp":1632982719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04986-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4986"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04986-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"29 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The other authors declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}}]}}